ORGANOSELENIDES AS POTENTIAL IMMUNOSTIMULANTS AND INDUCERS OF INTERFERON GAMMA AND OTHER CYTOKINES IN HUMAN PERIPHERAL-BLOOD LEUKOCYTES

被引:42
作者
INGLOT, AD [1 ]
ZIELINSKAJENCZYLIK, J [1 ]
PIASECKI, E [1 ]
SYPER, L [1 ]
MLOCHOWSKI, J [1 ]
机构
[1] WROCLAW TECH UNIV,INST ORGAN & PHYS CHEM,PL-50370 WROCLAW,POLAND
来源
EXPERIENTIA | 1990年 / 46卷 / 03期
关键词
antiviral agents; Ebselen; human peripheral blood leukocytes; interferon gamma; interferon inducers; Organoselenium compounds; phytohemagglutinin; tumor necrosis factor;
D O I
10.1007/BF01951774
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A number of organoselenium compounds have been described as anti-inflammatory, antioxidant, glutathione peroxidase-like agents and inhibitors of prostaglandin synthesis. Here we report that bis [2-(N-phenyl-carboxamido)]phenyl diselenide, 2-phenyl-1,2-benzisoselenazol-3(2H)-one (Ebselen) and related compounds are inducers of interferon gamma (IFN-γ) and tumor necrosis factor (TNF) in human peripheral blood leukocytes. The IFN and TNF response was rapid, occurring within 20 h, and high-up to 1000 and 2000 units ml-1-and was clearly related to the dosage and the structure of the compounds. The action of the compounds and phytohemagglutinin was synergistic. The IFN gamma and TNF production was reduced after removing adherent cells. Although the mode of action of the compounds is not known, they appear to interact directly or indirectly with both adherent and non-adherent leukocytes, and stimulate the synthesis of a set of different cytokines including factors controlling the cell proliferation. Therefore, organoselenides may be regarded as the biological response modifiers. © 1990 Birkhäuser Verlag.
引用
收藏
页码:308 / 311
页数:4
相关论文
共 17 条
[1]   A MACROPHAGE-DERIVED FACTOR DIFFERENT FROM INTERLEUKIN-1 AND ABLE TO INDUCE INTERFERON-GAMMA AND LYMPHOPROLIFERATION IN RESTING LYMPHOCYTES-T [J].
ANTONELLI, G ;
DIANZANI, F ;
VANDAMME, J ;
AMICUCCI, P ;
DEMARCO, F ;
CEFARO, A .
CELLULAR IMMUNOLOGY, 1988, 113 (02) :376-386
[2]  
CANTELL K, 1986, METHOD ENZYMOL, V119, P54
[3]  
HART PH, 1988, J IMMUNOL, V141, P1516
[4]  
INGLOT AD, 1983, ARCH IMMUNOL THER EX, V31, P601
[5]  
INGLOT AD, 1988, ARCH IMMUNOL THER EX, V36, P439
[7]  
JOHNSON HA, 1987, MECHANISMS INTERFERO, V2, P60
[8]  
LAMBERT C, 1987, B SOC CHIM BELG, V96, P383
[9]  
MANNERING GJ, 1986, ANNU REV PHARMACOL, V26, P455, DOI 10.1146/annurev.pa.26.040186.002323
[10]   A NOVEL BIOLOGICALLY-ACTIVE SELENOORGANIC COMPOUND .7. BIOTRANSFORMATION OF EBSELEN IN PERFUSED RAT-LIVER [J].
MULLER, A ;
GABRIEL, H ;
SIES, H ;
TERLINDEN, R ;
FISCHER, H ;
ROMER, A .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (06) :1103-1109